Eli Lilly and (LLY) | Stock Overview & Key Data

What is LLY's 52-week high and low?

In the last 52 weeks, Eli Lilly and reached a high of $1,182.73 (on June 8, 2026) and a low of $623.78 (on August 8, 2025).

What is the market cap and P/E ratio for LLY?

Curious about Eli Lilly and's size and valuation? Its market capitalization stands at 821.31B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.09, and the forward P/E (looking ahead) is 21.82.

Does LLY pay dividends? If so, what's the yield?

Yes, Eli Lilly and is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.60%, and the company has paid an average of $5.44 per share annually over the past 3 years.

Who are Eli Lilly and's main competitors or similar companies to consider before investing?

When looking at Eli Lilly and, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Johnson & Johnson JNJ	555.84B	Healthcare	Drug Manufacturers - General	53.32%	46.67%
AbbVie ABBV	351.47B	Healthcare	Drug Manufacturers - General	19.18%	64.26%
Merck & Co MRK	283.10B	Healthcare	Drug Manufacturers - General	45.70%	8.90%
Medicus Pharma MDPLD	N/A	Healthcare	Drug Manufacturers - General	N/A	N/A
Amgen AMGN	187.93B	Healthcare	Drug Manufacturers - General	20.32%	54.66%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Eli Lilly and Company? (e.g., ROE, Debt/Equity)

To get a sense of Eli Lilly and's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 101.16%, the Debt to Equity ratio from the most recent quarter is 165.31, and its Gross Profit Margin stands at 82.52%.

What is the recent revenue and earnings growth for LLY?

Looking at Eli Lilly and's growth, its revenue over the trailing twelve months (TTM) was $65B. Compared to the same quarter last year (YoY), quarterly revenue grew by 42.60%, and quarterly earnings saw a YoY growth of 50.50%.

How much of LLY stock is held by insiders and institutions?

Wondering who owns Eli Lilly and stock? Company insiders (like executives and directors) hold about 0.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 84.77%.

For more common questions about our data, please visit our About Data page.